WHO Label |
Pango Lineage• |
GISAID clade | Nextstrain clade | Changes in additional amino acids are monitored ° | Initial Documentation Sample | Appointment date |
---|---|---|---|---|---|---|
Alpha |
B.1.1.7 |
GRY |
20I (V1) |
+S:484K |
United Kingdom, |
18-Dec-2020 |
Beta |
B.1.351 |
GH/501Y.V2 | 20H (V2) | +S:L18F |
South Africa, May-2020 |
18-Dec-2020 |
Gamma |
P.1 |
GR/501Y.V3 | 20J (V3) | +S:681H | Brazil, Nov-2020 |
11-Jan-2021 |
Delta |
B.1.617.2 |
G/478K.V1 | 21A, 21I, 21J | +S:417N +S:484K |
India, Oct-2020 |
VOI: 4-Apr-2021 VOC: 11-May-2021 |
Omicron* | B.1.1.529 | GRA | 21K, 21L | +R346K | Several Countries, Nov-2021 | VUM: 24-Nov-2021 VOC: 26-Nov-2021 |
WHO Label | Pango Lineage* |
Clade GISAID | Nextstrain clade |
Early Documented sampel |
Appointment date |
---|---|---|---|---|---|
Lambda |
C.37 |
GR/452Q.V1 |
21G |
Peru, Des-2020 |
14-Jun-2021 |
mu | B.1.621 | GH | 21H | Kolombia, Jan-2021 | 30-Ags-2021 |
Pango Lineage* |
Clade GISAID | Nextstrain clade |
Early Documented Sampel |
Appointment date |
---|---|---|---|---|
AZ.5 # | GR | - | Several Countries, Jan-2021 |
VUM: 02-Jun-2021 |
C.1.2 | GR | - | South Afrika, Mei 2021 | 01-Sep-2021 |
B.1.617.1 § | G/452R.V3 | 21B | India, Okt-2020 | VOI: 4-Apr-2021 VUM: 20-Sep-2021 |
B.1.526 § | GH/253G.V1 | 21F | United States of America, Nov-2020 |
VOI: 24-Mar-2021 VUM: 20-Sep-2021 |
B.1.525 § | G/484K.V3 | 21D | Several Countries, Des-2020 |
VOI:17-Mar-2021 VUM: 20-Sep-2021 |
B.1.630 | GH | - | Republic of Dominica, Mar-2021 | 12-Oct-2021 |
B.1.640 | GH/490R |
- | Republic of the Congo, Sep-2021 | 22-Nov-2021 |
Updated SARS-CoV-2 classification, geographic distribution of VOCs, and summary of their phenotypic characteristics (transmission, disease severity, risk of reinfection, and impact on vaccine diagnostics and performance) based on published studies, regularly provided at WHO Weekly Epidemiology Update